Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Ebit
Keuangan
Harga Saham
USD
Aktiva
USD 12.05B
Kas Dan Setara
USD 1.02B
Biaya Penjualan
USD 312.82M
Aset Lancar
USD 2.3B
Kewajiban Lancar
USD 1.28B
UTANG
USD 3.35B
Dividen - Hasil
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
Karyawan
11K
Eps Laba Per Saham
USD 1.41
Modal Dan Cadangan
USD 7.18B
Laba Kotor Pada Penjualan
USD 416.87M
Beban Bunga Utang
USD 22.99M
Pendapatan Bunga
USD 6.3M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 14.51B
Batas Pemasukan
USD 51.82M
Biaya Operasional
USD 603.55M
Laba Operasional
USD 126.14M
Modal Saham Biasa
USD 111.63M
Pe Harga Untuk Laba
36.47
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729.68M
Beban Penjualan Dan Administrasi
USD 278.58M
Saham
USD 378.5M
Kreditur Perdagangan
USD 165.74M
Debitur Perdagangan
USD 709.18M
Ebit
Perubahan
Tanggal
Agilent
USD 399M
46M
2026-03
Align Technology
USD 191.32M
13.27M
2026-06
Bio Techne
USD 75.49M
21.03M
2026-03
Bio-Rad Laboratories
USD 72.6M
750.1M
2026-06
Bruker
USD 69.6M
59.4M
2026-06
Celltrion
KRW 13.41B
1.33B
2026-03
Charles River Laboratories
USD 119.89M
9K
2026-06
Cspc Pharmaceutical
CNY 206.26M
1.02B
2025-12
Danaher
USD 1.13B
217M
2026-06
Dentsply International
USD 84M
52M
2026-06
Deva Holding AS
TRY 820.88M
192.13M
2023-09
Dianthus Therapeutics
USD -46.53M
23.01M
2026-03
Divis Laboratories Ltd
INR 11.29B
3.15B
2026-06
Edwards Lifesciences
USD 519.5M
4.8M
2026-06
Illumina
USD 260M
21M
2026-06
Intuitive Surgical
USD 977.6M
117.9M
2026-06
IQVIA Holdings
USD 2.6B
2.03B
2026-06
Kangmei Pharma
CNY -12.72M
13.97M
2026-03
Knight Therapeutics
CAD 6.21M
3.27M
2025-12
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Laboratory Of America
USD 456.7M
46.6M
2026-06
Malin Corporation
EUR -1.1M
300K
2024-12
Medical Developments International
AUD -36K
12.96M
2025-12
Mesa Laboratories
USD 4.45M
2.5M
2024-09
Mettler Toledo International
USD 287.55M
53.61M
2026-06
Myriad Genetics
USD -3M
20.3M
2025-12
Neuren Pharmaceuticals
AUD 17.01M
154.09M
2025-12
OraSure Technologies
USD -13.59M
2.13M
2025-12
Organigram Holdings
CAD -9.79M
10.33M
2026-03
Ovoca Bio
EUR -173K
990K
2025-12
Pacific Biosciences Of California
USD -53.19M
35.08M
2025-12
Pharma Mar
EUR -1.4M
2.03M
2026-06
Qiagen NV
USD 141.4M
44.52M
2026-06
Quest Diagnostics
USD 459M
60M
2026-06
Quidel
USD -15.3M
12.1M
2026-06
Repligen
USD 21.13M
1.15M
2026-06
Revvity
USD 126.14M
43.36M
2026-06
Sartorius
EUR 164M
3.3M
2026-06
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
Thermo Fisher Scientific
USD 2.18B
273M
2026-06
Tilray
USD -20.01M
9.34M
2025-09
Waters
USD 10M
138M
2026-06
Zealand Pharma A/S
-389M
318.05M
2026-03
Zz Pientze Pharmaceu
CNY 837.81M
336.48M
2026-03
×